A Safety & Efficacy Study of Treatment With AP1189 in Rheumatoid Arthritis Patients naïve to DMARD Treatment
Clinical trial NCT05516979 · COMPLETED
Trial details
- NCT number
- NCT05516979
- Sponsor
- SynAct Pharma Aps
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-26
- Primary completion
- 2023-07-20
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.